In this case, CD21 and CD35 were positive and CD45 was weakly positive; T and B cell markers were negative; MPO was positive, but CD117, CD15, and CD68 were negative; therefore, myeloid sarcoma and acute myeloid leukemia were not considered. This evidence concerns the gene CR2 and myeloid sarcoma.